Royalty Report: Device, Medical, Personal Care Products – Collection: 203491

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 20

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 20

Primary Industries

  • Device
  • Medical
  • Personal Care Products
  • Surgical
  • Therapeutic
  • Skin care
  • Scientific & Technical Instruments
  • Delivery
  • Diagnostic
  • cardiac
  • Disposable
  • Laser
  • Drugs
  • Pharmaceuticals
  • Pain

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 203491

License Grant
The University hereby grants to the Licensee a co-exclusive license (with New Star) to the Regents Patent Rights, for the following fields of use (i) for procedures that involve non-ablative laser skin rejuvenation including collagen formation, collagen remodeling, skin smoothing and wrinkle treatment, (ii) for procedures that involve the treatment of facial and lower extremities telangiestasias and spider veins and (iii) for procedures using a long pulse [0.2 – 500 milliseconds] 1.06 UM Nd.YAG laser (collectively, the 'Co-exclusive Fields of Use') and grants to the Licensee an exclusive license to the Regents Patent Rights for the following fields of use for procedures that involve (i) vascular skin lesions and (ii) laser hair removal (collectively, the 'Exclusive Fields of Use'), to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method. The Regents hereby grants to Licensee a non-exclusive license under The Regents Patent Rights to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method in any fields of use not covered by the Co-exclusive Fields of Use and the Exclusive Fields of Use. The Regents specifically retains all rights to grant Further Licenses to The Regents Patent Rights to any party for fields of use not covered by the Co-Exclusive Fields of Use and the Exclusive Fields of Use.

This Agreement grants the exclusive right, co-exclusive right, or nonexclusive right to use or sell the Patent Products in the United States within specified fields of use, Licensee agrees that any Patent Products embodying the Regents Patent Rights or produced through the use thereof will be manufactured substantially in the United States.

License Property
Regents Patent Rights means all U.S. patents and patent applications and foreign patents and patent  applications assigned to The Regents, including any reissues, extensions, substitutions, continuations, divisions and continuations-in-part (only to the extent, however, that claims in any continuations-in-part not listed below are entitled to the priority filing date of any of the below listed patents and patent applications) based on and including any subject matter claimed in or covered in U.S. Patent Application Serial Number 08/222,976 entitled 'Apparatus and Method for Dynamic Cooling of Biological Tissues for Thermal Mediated Surgery' now  abandoned; filed April 5, 1994; and assigned to The Regents. As of the effective date of this Agreement, the Regents Patent Rights include the following patents and patent applications
93-364-2            08/441930                                US    5,814,040 issued 09/29/98
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery
93-364-3            08/870467                                US   5,979,454 issued 11/09/99
Method and apparatus for causing rapid and deep spatially selective coagulation during thermally mediated therapeutic procedures
93-364-4            08/963531                                US   6,171,301 B1 issued 01/09/01
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery

Patent Products means any kit, composition of matter, material, or product whose manufacture, use, or sale in a particular country would infringe, but for the license granted to Licensee pursuant to this Agreement, an unexpired Claim of a patent or pending claim of a patent application under Regents Patent Rights in that country in which such patent has issued or application is pending; any kit, composition of matter, material, or product to be used in a manner requiring the performance of the Patent Method; or any kit, composition of matter, material, or product produced by the Patent Method. This definition of Patent Products also includes a service either used by Licensee or provided by Licensee to its customers when such service requires the practice of the Patent Method. Dynamic Cooling Device (or DCD) means a cooling device for use with a laser system, the combination of which utilizes the Regents Patent Rights. DCDs, whether sold as (i) an accessory or upgrade product to a laser system or (ii) integrated with a laser system as one product, are Patent Products.

Field of Use
Dynamic Cooling Device (DCD) is a device which cools the top layer of the skin, while leaving the targeted underlying hair follicle, vein or other structure at normal temperature. As a result, higher levels of laser energy can be delivered during treatment, while minimizing thermal injury, pain, and the inconvenience associated with anesthetics. The design of the hand-held DCD enables the practitioner to clearly see the area being treated, and the combined efficiency of the lasers and DCD reduces the risks of over treatment. The DCD delivers the appropriate amount of cooling quickly and consistently.

IPSCIO Record ID: 6577

License Grant
The Company entered into an agreement to amend its license agreement with the University whereby in exchange for an exclusivity fee, the Company obtained exclusive license rights to the Dynamic Cooling Device (DCD) subject to certain limited license rights of Cool Touch in the following fields of use procedures that involve skin resurfacing and rejuvenation, vascular skin lesions, and laser hair removal. Cool Touch, a subsidiary of New Star Technology, Inc. obtained a license to the DCD on a co-exclusive basis with the Company in certain narrower fields of use. Cool Touch is restricted in its ability to assign its license rights to certain existing competitors of the Company.
License Property
Dynamic Cooling Device (DCD) is a device which cools the top layer of the skin, while leaving the targeted underlying hair follicle, vein or other structure at normal temperature. As a result, higher levels of laser energy can be delivered during treatment, while minimizing thermal injury, pain, and the inconvenience associated with anesthetics. The design of the hand-held DCD enables the practitioner to clearly see the area being treated, and the combined efficiency of the lasers and DCD reduces the risks of over treatment. The DCD delivers the appropriate amount of cooling quickly and consistently.
Field of Use
Licensee offers a comprehensive range of products based on proprietary technologies focusing on the major aesthetic and cosmetic laser applications.

IPSCIO Record ID: 4128

License Grant
Licensor hereby grants to Licensee a royalty-bearing worldwide, non-exclusive right and license under the Patent Rights to make and have made, use,  import, offer to sell, sell, or otherwise exploit or dispose of any article of manufacture, product, service, component or matter, and to practice and have practiced any method, process or procedure within the Patent Rights, provided that Licensee may not exercise it's have made and have practiced rights with any Lumenis Competitors.
License Property
United States P-1733-US 08/535,705  5,836,999
  Method And Treatment For Treating Psoriasis using Pulsed Electromagnetic Radiation

United States P-1755-US1 08/529,044  5,964,749
   Method And Apparatus For Skin Rejuvenation and Wrinkle Smoothing

Field of Use
The rights granted apply to treating psoriasis and skin rejuvenation.

IPSCIO Record ID: 5832

License Grant
Licensor hereby grants to Licensee and Licensee Affiliates a worldwide, royalty-bearing, non-exclusive sublicense, under the Anderson Patents, to make, use, sell, offer for sale and import Licensed Products (provided that those Licensee Hair Modules that alone amount to a Licensee Product hereunder are used exclusively with other Licensee Products or Licensee Other Products and no other products or systems of Licensee, Licensee Affiliates or any Third Parties), in each case only for hair removal and only outside of the Consumer Field.
License Property
The Company entered into a non-exclusive Cross License Agreement. The Company obtained the non-exclusive license to integrate into its products certain hair removal technology covered by specified U.S. and foreign patents. U.S. Patent Nos. 5,595,568 & 5,735,844.
Field of Use
Consumer Field shall mean the field in which products or systems are intended for or marketed to consumers for personal use. For the avoidance of doubt, the Consumer Field shall exclude products or systems in the Professional Field.

IPSCIO Record ID: 587

License Grant
The Licensor announced a settlement with the licensee resolving on-going litigation concerning both patent infringement and contractual matters. Pursuant to the settlement, the parties dismissed with prejudice both the federal action in the Northern District of California as well as the state court action in Massachusetts. Both parties executed a Settlement Agreement and a Patent License Agreement. Under the Patent License Agreement, the Licensor granted the Licensee a non-exclusive, royalty bearing License to the Anderson Patents in the professional field, excluding the consumer field which is exclusively licensed to the Gillette Company.
License Property
The Anderson Patents include U.S. Patent Nos. 5,595,568 & 5,735,844.

Intellectual property relates to the LightSheer and other professional laser hair removal devices and modules.

Field of Use
Field shall mean the field in which products or systems are intended or marketed for sale to doctors, health care providers, beauty care professionals or other commercial service providers for use on or with patients or customers and not for resale to any person or entity for personal use.

IPSCIO Record ID: 115864

License Grant
The University grants to the Licensee a worldwide license under Licensors Patent Rights to make, have made, use, sell, and distribute Licensed Products and to practice Licensed Method.  The Licensor also grants to the Licensee the right to issue sublicenses to third parties to make, have made, use, sell, and distribute Licensed Products and to practice the Licensed Method.
License Property
The license is for certain inventions, generally characterized as a noninvasive continuous iontophoretic blood monitor/drug delivery system.  Patents relates to devices for iontophoretic non-invasive sampling of substances.

The Licensed Product is any material that is either covered by Licensor’s Patent Rights or any product manufactured using the Licensed Method, in either event to the extent the manufacture, use or sale of which in a particular country infringes an unexpired valid claim of a patent or a pending claim of a patent application under Patent Rights in that country in which such patent has issued or application is pending.

The Licensed Method is any method that is covered by the claims of Licensor’s Patent Rights in the country in which such method is used, or the use or practice of which would constitute, but for the license granted to the Licensee pursuant to this Agreement, an infringement of any unexpired, valid issued claim or pending claim under Patent Rights in that country in which the Licensed Method is used or practiced.

(a) U.S. Patent Application serial no. 150,159, filed 29 Jan 88,(abandoned) by Dr. Richard Guy, et al., and assigned to The Regents;

(b) U.S. Patent Application serial no. 299,397, filed 24 Jan 89, as a continuation-in-part application of (a), (abandoned) by Dr. Richard Guy, et al., and assigned to The Regents;

(c) U.S. Patent Application serial no. 771,483, filed 04 Oct 91, as a continuation-in-part of (b) (now allowed) by Dr. Richard Guy, et al., and assigned to The Regents;

(d) U.S. Patent No. 5,279,543, issued 18 Jan 94, which was a file wrapper continuation application of (b), by Dr. Richard Guy, et al, and assigned to The Regents; and continuing applications thereof including divisions and substitutions but including continuation-in-part applications only to the extent that the claim was supported in the original disclosure; any patents issuing on said application or continuing applications including reissues and extensions; and any corresponding foreign applications or patents.

Field of Use
This agreement pertains to drug delivery systems.  The Licensee, GlucoWatch system is designed to measure glucose frequently, automatically and non-invasively through the ease and convenience of a device worn like a wristwatch.

IPSCIO Record ID: 27222

License Grant
The Licensor granted the Licensee a non-exclusive sublicense in the field of hair removal under the MGH patents.  Patented invention pertaining to the use of lasers for hair removal; LightSheer diode laser system (Patent No.  5,595,568).
License Property
United States Patent No. 5,595,568  (Permanent Hair Removal Using Optical Pulses).
Field of Use
The rights granted apply to hair removal.

IPSCIO Record ID: 28651

License Grant
Assignors, two individuals, hereby sell, assign, and transfer exclusively and subject to all of the terms and conditions of this Agreement, their entire right, title, and interest in and to the Device and the Intellectual Property.
License Property
“Applications” shall mean any and all pending patent applications filed by Assignors relating to the Device and any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure designed or used by Assignors, including, but not limited to, the following
(a) In the United States, application No. 09/733,224 entitled Annuloplasty System, filed December 8, 2000;
(b) In Canada, application No. 2,197,069 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995;
(c) In the European Region, application No. 95929486.9 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995; and
(d) In Japan, application No. 507532/1996 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995 and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which either Segmed or Dr. Northrup is an inventor, which relate to the Device and/or any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom; and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by either or both of the Assignors, and any patent applications therefor and any patents issuing therefrom.

“Device” shall mean the apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure (the “Field”) covered by the Intellectual Property and fully described in the Applications and applications relating to the Patents, and any and all improvements, modifications, derivations, enhancements, technology, Know-how and Documentation related thereto.

Patent relates to a new annuloplasty technology for the repair of mitral and tricuspid heart valves.

“Patents” shall mean the following patents issued to Assignors in the United States, Australia, Taiwan and South Africa
(a) In the United States, U.S. Patent No. 5,593,424 entitled Apparatus and Method for Reducing and Stabilizing the Circumference of a Vascular Structure, issued January 14, 1997, U.S. Patent No. 5,709,695 entitled Apparatus for Reducing the Circumference of a Vascular Structure, issued January 20, 1998, and U.S. Patent No. 5,961,539 entitled Method and Apparatus for Sizing, Stabilizing and/or Reducing the Circumference of an Anatomical Structure, issued October 5, 1999;
(b) In Australia, patent No. 700530 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995;
(c) In Taiwan, patent No. 096871 entitled Apparatus for Reducing the Circumference of a Bodily Structure, filed August 11, 1995; and
(d) In South Africa patent No. 95/6672 entitled Apparatus and Method for Reducing the Circumference of a Vascular Structure, filed August 10, 1995,
and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which Assignors are an inventor, which relate to the Device and/or any apparatus or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom, and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by Assignors, and any patent applications therefor and any patents issuing therefrom.

“Trademark” shall mean the mark represented by United States Registration No. 2,108,883 for the “SEGMENT” mark.

IPSCIO Record ID: 246730

License Grant
As a center for research and education, Hospital is interested in licensing additional Patent rights and Photon Recycling Patent Rights and Licensee having such capacity, desires to commercially develop, manufacture, use and distribute such products throughout the world, the Hospital and Licensee hereby agree to amend the License Agreement and all references in the License Agreement shall be deemed to be references to such License Agreement as amended hereby to include

a) an exclusive, worldwide, royalty-bearing license in all fields under Hospital’s rights in additional Patent Rights to make, have made, use and sell products and to perform services; and
b) a non-exclusive, worldwide, perpetual, irrevocable, fully paid up license in all fields under Hospital’s rights in Photon Recycling Patent Rights to make, have made, use and sell products and to perform services.

License Property
The product consists of the SLP1000 Diode Laser System and associated hand pieces (“SLP1000”) and the EsteLux Pulsed-Light System and associated hand pieces (“EsteLux”) for hair removal and other applications.

The term Photon Recycling Patent Rights shall mean Hospital’s rights in U.S. Patent No. 5,824,023, filed April 16, 1996 and entitled “Radiation-Delivery Device”, including any division, continuation or any foreign patent application or Letters Patent or the equivalent thereof issuing thereon or reissue, reexamination or extension thereof. Photon Recycling Patent Rights shall also include those claims in any continuation-in-part which claims an invention described or claimed in U.S. Patent No. 5,824,023.

The term Additional Patent Rights shall mean Hospitals rights in
(i) U.S. Patent Number 6,273,884 issued August 14, 2001 and entitled 'Method and Apparatus for Dermatology Treatment'
(ii) U.S. Patent Number 6,511,475 issued January 28, 2003 and entitled 'Heads for Dermatology Treatment' (CIP off 6,273,884)
(iii) Utility Patent Application Serial Number 10/274,582, filed October 21, 2002 and entitled 'Heads for Dermatology Treatment' (divisional off 6,511,475)
(iv) Utility Patent Application Serial Number 09/277,307 filed March 26, 1999 and entitled 'Method and Apparatus for the Selective Targeting of Lipid-Rich
Tissues'
(v) Utility Patent Application Serial Number 09/769,960 filed January 25, 2001 and entitled 'Method and Apparatus for EMR Treatment'
(vi) Utility Patent Application Serial Number 10/033,302 filed December 27, 2001 and entitled 'Method and Apparatus for EMR Treatment'
(vii) Provisional Patent Application Serial Number 60/363,871 filed March 12, 2002 and entitled 'Method and Apparatus for Hair Growth Control'
(viii) Provisional Patent Application Serial Number 60/389,871 filed June 19, 2002 and entitled 'Method of Selectively Heating Subcutaneous Fat', and any other divisional or continuation patent applications naming one or more Hospital employees as inventors to the extent the aforementioned are jointly owned with Licensee.

Field of Use
The Licensee splits its efforts between new products for existing markets such as the removal of unwanted hair, vascular and pigmented lesions and tattoos, and new products for markets, such as acne treatment, fat reduction and wrinkle removal.

IPSCIO Record ID: 233464

License Grant
Licensor grants a non-exclusive, worldwide license, without the right to sublicense, to make, have made, use, import, sell, offer for sale, or otherwise dispose of Licensed Products, and to practice any method or process involved in the manufacture, testing or use thereof, under the Licensed Licensor Patents.
License Property
Licensor is the exclusive licensee of U.S. Patent No. 4,784,135 and  No. 4,686,979.

The Licensed Products means Lasers, and, Disposables.  Laser shall mean any source of amplified, coherent light having a wavelength between 100 and 400 nanometers.  Disposable shall mean apparatus comprised, at least in part, or one of more optical fibers, that is or may be coupled to a Laser, as hereinafter defined, to guide the light emitted from that Laser to a treatment location within a human or animal body. Such apparatus shall fall within the definition of Disposable irrespective of whether it is intended for use in more than one procedure.

Field of Use
This agreement is for the field of transmyocardial revascularization or percutaneous transmyocardial revascularization.

Transmyocardial laser revascularization (TMR) is a procedure used to treat inoperable heart disease in people with persistent angina that isn't relieved by any other revascularization method.

IPSCIO Record ID: 27743

License Grant
This agreement gives the company a non-exclusive royalty bearing sublicense to skin cooling patents for use in laser hair removal.
License Property
The license provides the Apex 800 hair removal system with additional cooling features.

U.S. Patent No. 5,595,568 entitled 'Permanent Hair Removal Using Optical Pulses,' and U.S. Patent No. 5,735,844 entitled 'Hair Removal Using Optical Pulses.'

Field of Use
The Apex 800 is a high powered infrared laser for hair removal for the aesthetics market.

IPSCIO Record ID: 29205

License Grant
Under the Settlement Agreement, the Licensee obtains a non-exclusive license to utilize the patented (5,735,844 and 5,595,568) technology in its product line.
License Property
The suit involves certain U.S. hair removal patents. A method and apparatus for simultaneously effecting the removal of multiple hairs from a skin region by using light energy to destroy hair follicles in the region. Light energy is applied to the region through an applicator which converges the light energy to enhance destruction of desired portions of the follicles, is preferably pressed against the skin region to deform the upper layers of the skin reducing the distance from the skin surface to portions of hair follicles which are to be destroyed, including the bulge and papilla of the follicles, and which applicator is preferably cooled to minimize or eliminate thermal damage to the epidermis in the region being irradiated. Parameters for the irradiation, including pulse duration, are selected to effect complete damage of desired portions of the hair follicles in the region with minimal damage to surrounding tissue and to the patient's epidermis.
Field of Use
The rights granted apply to hair follicles.

IPSCIO Record ID: 28030

License Grant
HOSPITAL hereby grants to COMPANY in the LICENSE FIELD in the LICENSE TERRITORY for the LICENSE TERM
  (i) an exclusive, royalty-bearing license under PATENT RIGHTS to make, have made, use, have used, sell, offer to sell, have sold, and TRANSFER PRODUCTS and to use, have used, otherwise practice and have practiced and TRANSFER PROCESSES;

  (ii) the nonexclusive right to disclose, use and transfer TECHNOLOGICAL INFORMATION disclosed by HOSPITAL to COMPANY hereunder; and

  (iii) the right to grant sublicenses under the rights granted.

License Property
This product has achieved FDA clearance, to market CoolSculpting, for the selective reduction of fat.

The Licensee is a medical technology company focused on developing and commercializing products utilizing the proprietary controlled-cooling technology platform.

The first commercial product, the CoolSculpting System, selectively reduces stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

CoolSculpting utilizes precisely controlled cooling to reduce the temperature of fat cells in the treated area, which leads to fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. Our clinical studies demonstrate that a single CoolSculpting procedure safely, noticeably, and measurably reduces the fat layer within a treated fat bulge without requiring the patient to diet or exercise.

PATENT RIGHTS  1. US Utility Patent Application, Serial
No. 10/391,221, filed on March 17th, 2003,
claiming priority from US Provisional Application, Serial No. 60/365,662, filed on March 15th, 2003.  2. US Utility Patent Application, Serial No. 11/016,196, filed
on December 17th, 2003, a continuation in part of US
Utility Patent Application, Serial No 10/391,221.  3. PCT Patent Application, Serial No. US03/08014, filed on March 17, 2003.
4. Australia Patent Application No. 2003220311, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
5. Brazil Patent Application No. 0308642.9, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
6. Canada Patent Application No. 2,478,887, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
7. China Patent Application No. 03810938.7, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
8. Israel Patent Application No. 164115, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
9. Japan Patent Application No. 2003-576590, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
10. Mexico Patent Application No. 2004-008992, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
11. EPO Patent Application No. 03711609.7, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.

Field of Use
License Field shall mean removal of cutaneous, subcutaneous or subdermal fat, treatment or removal of cellulite, andany therapy or procedures (including without limitation aesthetic therapies or procedures) to the tissues and structures of the skin (including without limitation sweat glands and hair follicles), subcutaneous tissue, and tumors, lesions and adipose tissue of the skin and of subdermal tissue

The Licensee shall itself or through an Affiliate or sublicensee make a first commercial sale within the following countries and regions within the following number years after the effective date of the Agreement
United States of America – Six years
Japan – Seven years
Latin America – Seven years
EPO – Seven years

IPSCIO Record ID: 28590

License Grant
Hospital hereby grants to Company the following

(i) an exclusive, royalty-bearing license under patent rights to make, have made, use, have used, sell, offer to sell, have sold, and Transfer Products and to use, have used, otherwise practice and have practiced and Transfer Processes;

(ii) the nonexclusive right to disclose, use and Transfer Technology IinformationTechnological Information disclosed by Hospital to Company hereunder; and

(iii) the right to grant sublicenses under the rights granted in Section 2.l(a)(i) and 2.1(a)(ii) to Sublicensees, provided that in each case Compny shall be responsible for the performance of any obligations of Sublicensees relevant to this Agreement as if such performance were carded out by Company itself, including, without limitation, the payment of any royalties or other payments provided for hereunder, regardless of whether the terms of any sublicense provide for such amounts to be paid by the Sublicensee directly to Hospital.

License Property
This product has achieved FDA clearance, to market CoolSculpting, for the selective reduction of fat.

The Licensee is a medical technology company focused on developing and commercializing products utilizing our proprietary controlled-cooling technology platform.

Our first commercial product, the CoolSculpting System, selectively reduces stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

CoolSculpting utilizes precisely controlled cooling to reduce the temperature of fat cells in the treated area, which leads to fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. Our clinical studies demonstrate that a single CoolSculpting procedure safely, noticeably, and measurably reduces the fat layer within a treated fat bulge without requiring the patient to diet or exercise.

PATENT RIGHTS
1. US Utility Patent Application, Serial No- 10/391,221, filed on March 17th, 2003, claiming priority From US Provisional Application, Serial No. 60/365,662, filed on March 15th, 2003.
2. US Utility Patent Application, Serial No. 11/016,196, filed on December 17th, 2003, a continuation in part of US Utility Patent Application, Serial No 10/391,221.
3. PCT Patent Application, Serial No. US03/08014, filed on March 17, 2003.
4. Australia Patent Application No 2003220311, claiming priority from PCT Patent Application No. PCT/US03/08014, tiled on March 17th, 2003.
5. Brazil Patent Application No, 0308642.9, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
6. Canada Patent Application No. 2,478,887, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
7. China Patent Application No, 03810938.7, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
8. Israel Patent Application No. 164115, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
9. Japan Patent Application No. 2003-576590, claiming priority from PCT Patent Application No PCT/US03/08014, filed on March 17th, 2003.
10. Mexico Patent Application No. 2004-008992, claiming priority from PCT Patent Application No PCT/US03/08014, filed on March 17th, 2003.
11. EPO Patent Application No. 03711609.7, claiming priority from PCT Patent Application No, PCT/US03/08014, filed on March 17th, 2003.

Field of Use
“LICENSE FIELD” shall mean removal of cutaneous, subcutaneous or subdermal fat, treatment or removal of cellulite, and any therapy or procedures (including without limitation aesthetic therapies or procedures) to the tissues and structures of the skin (including without limitation sweat glands and hair follicles), subcutaneous tissue, and tumors, lesions and adipose tissue of the skin and of subdermal tissue.bb

IPSCIO Record ID: 266122

License Grant
The Company agreed to purchase the rights to the Licensors U.S. Patent No. 7,963,959.
License Property
U.S. Patent No. 7,963,959 'Automated Cryogenic Skin Treatment'.
Field of Use
This agreement pertains to the healthcare industry relating to an apparatus and methods for treating lesions on skin.

IPSCIO Record ID: 25834

License Grant
The Licensor hereby grants to Licensee a worldwide, royalty-bearing, non-exclusive sublicense, under the Anderson Patents to make, use, sell, offer for sale and import Licensed Products.
License Property
Licensed Products shall mean Laserscope Products including those Laserscope Hair Modules that alone amount to a Laserscope Product.

Laserscope Hair Module shall mean any energy source module, sold by Laserscope or Laserscope Affiliates, that is marketed as being capable of using or uses or is incorporated into a product or system that uses optical radiation to remove hair.

Laserscope Other Module shall mean any energy source module, sold by Laserscope or Laserscope Affiliates, that is marketed as being capable of using or uses or is incorporated into a product or system that uses optical radiation for the treatment of skin including treatment of vascular and pigmented lesions, acne, fat, cellulite, wrinkles, scars and tattoos, skin tightening, and for other dermatological applications.

The Anderson Patents include patents 5,595,568 & 5,735,844, 5,824,023.

Field of Use
Field shall mean the field in which products or systems are intended for or marketed to consumers for personal use.

IPSCIO Record ID: 299260

License Grant
The Israel Licensor and Licensee intend to jointly develop one or more Devices to be commercially sold for use in the field (the “Project”). The Parties’ shall, promptly upon execution of this Joint Development and Supply Framework Agreement (JDSA), agree on a plan for the Project (the Project plan). Each Party shall perform the duties and obligations assigned to it under the Project plan, on the timeline set forth therein.

Each Party agrees to fully cooperate with the other Party and hereby assigns to the other Party the Project patents and Project know-how to the extent necessary to achieve the ownership and other rights set forth in this Agreement. This includes, but is not limited to, reviewing patent applications and providing comments to the same, providing comments to facilitate prosecution or opposition of the other Party’s patent application or a joint patent application, providing data or evidence of patentability required for prosecution or opposition and executing assignment documents and instruments reasonably necessary to evidence or record such assignment or to enforce rights in the assigned intellectual property.

License Property
Device Devices that utilize RF alone or a combination of RF energy plus optical radiation and or other types of energy sources, to achieve one or more Benefits.

Project Patent  Any Patent claiming a Project invention.

Project patent – Device Any Project patent wherein (a) each of the claims covers at least one of the following, or covers a combination of any of the following any Device, Device component, RF and/or optical radiation or other types of energy sources, or method of making or using any of the same; and (b) no such claims cover, or include limitations directed specifically to, any of the following, or a combination of any of the following any Personal Care Composition, ingredient(s) thereof, or a method of making or using any of same, or Licensee Device technology. None of the individual items listed in clause (a) shall be used to interpret or limit the scope of other items listed in such clause (there is overlap among categories).

Project invention Any invention conceived and/or reduced to practice (a) by Licensor employees or other agents (whether solely or jointly with another), (b) by Licensee employees or other agents (whether solely or jointly with another), or (c) by at least one of each of the foregoing in (a) and (b), in each case (x) pursuant to their conduct of the Project, or (y) using the other Party’s materials that are (or were prior to the effective date) received in connection with (or in preparation for) the Project or otherwise pursuant to this JDSA.

Personal Care Composition Topical formulations and compositions for application to keratinous tissue (including skin, hair, and nails) marketed to consumers for using either during operation of the Device or within a treatment regimen(s) using the Device. Such a regimen includes pre-and post treatment lotions, but excludes cleansers, daily use lotions or other general use lotions.

Device technology All technology solely developed by Licensee pertaining to delivery, distribution and/or application of compositions from a device, aesthetic or ergonomic aspects of devices, consumables other than consumables utilized for the administration of energy or cooling of the skin or otherwise retro-fitted components for use with devices other than components utilized for the administration of energy or cooling of the skin, discoveries and inventions related to the marketing of devices, discoveries and inventions related to the consumer use or consumer interface that’s associated with the use of the device by the consumer, methods of use of devices within the field, business methods associated with marketing devices within the field, discoveries and inventions related to safety aspects of devices.

Intellectual property or IP Inventions, discoveries and technology, whether patentable or not, and all patents, registrations, invention disclosures and applications therefore, including divisions, continuations, continuations-in-part, and renewal applications, and including renewals, extensions, re-examinations and reissues; (ii) Confidential Information, trade secrets and know-how, including processes, schematics, business methods, formulae, drawings, prototypes, models, designs, customer lists and supplier lists (collectively, “Trade Secrets”); (iii) published and unpublished works of authorship, whether copyrightable or not (including, without limitation, databases and other compilations of Information), copyrights therein and thereto, and registrations and applications therefore, and all renewals, extensions, restorations and reversions; and (iv) all other intellectual property or proprietary rights.

Benefit Enhancement of skin appearance with respect to preventative and therapeutic treatment of, the following conditions fine lines, wrinkles, hyperpigmentation, superficial and benign vascular and pigmented lesions, such as telangiectasias, rosacea, poikiloderma, cellulite and angioma, but not including (and explicitly excluding) the following conditions and applications adipose tissue, skin recontouring or reshaping, fat reduction, lypolysis, acne, leg veins, hair removal, and the inhibition, prevention, reduction, or slowing of hair growth.

Field of Use
Field In-home use to obtain one or more Benefits using the Device. The Field shall not include (and explicitly excludes) use in clinical settings, use in spa settings, and use by Professionals in treating patients or clients.

This agreement pertains to the medical industry relating to in-home personal use that utilize radio frequency (“RF”) alone or a combination of RF and optical radiation and/or other types of energy sources, alone or when in conjunction with Personal Care Compositions, to enhance an individual’s skin appearance.

IPSCIO Record ID: 118680

License Grant
Licensor granted us a non-exclusive license to its patent covering excimer laser ablation of tissue.  The terms of the license permit us to sublicense our subsidiaries.
License Property
The excimer laser systems and related products are used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
Field of Use
Laser vision correction is a surgical procedure for correcting disorders such as nearsightedness, farsightedness and astigmatism using an excimer laser. This procedure uses ultraviolet laser energy to remove tissue from the surface of, and thus sculpt, the cornea into a predetermined shape. Because the excimer laser is a cold laser, it is possible to ablate, or remove precise amounts of corneal tissue without causing thermal damage to surrounding tissue. The goal of laser vision correction is to eliminate or reduce a persons reliance on corrective eyewear.

IPSCIO Record ID: 290317

License Grant
University hereby grants to Company an exclusive license in the Field under its interest in and to the Licensed Patents, to make, use, offer to sell, sell and import Licensed Products during the Term. No right to sublicense the Licensed Patents are granted under this Agreement.
License Property
Licensed Patents shall mean the patent applications and issued patents listed hereto and made a part hereof; any divisions, continuations (but excluding continuations-in-part) or patents issuing thereon or reissues thereof; and any and all United States and foreign patents and patent applications corresponding thereto, all to the extent controlled by University.

Application #14/256,540 – System and Apparatus for Endoscopic Deployment of Robotic Concentric Tube Manipulators for Performing Surgery
Application #62/236,187 – Hand-held Concentric Tube Manipulator Actuation Unit and Mechanism for Surgery

Licensed Product shall mean (i) any product, process, or service in the Field (a) the making, use, sale, offer to sell, or import of which is covered by (in whole or in part), or absent the license granted herein would infringe, one or more Valid Claims, or (b) that is made, uses, or is used by or in a process that is covered by (in whole or in part), or absent the license granted herein would infringe, one or more Valid Claims, or (ii) a service performed using a product or process described in subsection (i)(a) or (b) above.

Field of Use
This agreement pertains to the medical industry in the field that shall mean human surgical applications.

IPSCIO Record ID: 25850

License Grant
The University granted the Licensee an exclusive license to  make, have made, use, sell, offer to sell, import, have imported, and otherwise exploit Licensed Products and to practice Licensed Methods.  The inventions, generally characterized as High Dose Capsaicin Relieves Neuropathic Pain (or High Dose Capsaicin for Neuropathic Pain) UCSF Case No. SF00-056.
License Property
Patent Rights means the Regents’ interest in any subject matter claimed in or covered by any of the following Pending U.S. Patent Application Serial No. 08/746,207 entitled Therapeutic Method with Capsaicin and Capsaicin Analogs filed November 6, 1996, the continuation-in-part U.S. Patent Application Serial No. 08/990,633 entitled Transdermal Therapeutic Device and Method with Capsaicin and Capsaicin Analogs filed December 15, 1997 and assigned to The Regents; pending PCT Patent Application Serial No. PCT/US98/25794 of the same title, filed December 8, 1998 and assigned to The Regents; and continuing applications thereof including divisions, substitutions, continuation-in-part applications (but only to the extent however, that claims in the continuation-in-part applications are entitled to the priority filing date of the foregoing applications); any patents issuing on said applications including reissues, reexaminations and extensions; and any corresponding foreign applications or patents based on said applications.
Field of Use
The rights granted apply to the healthcare industry.  Field of Use means all fields and uses.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.